Healthcare

Vascular Embolization Market Growth Trajectory Through 2024-2033|Johnson and Johnson Co, Abbott Laboratories, Medtronic Plc., Merck Group, Stryker Corporation

The Vascular Embolization Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Vascular Embolization Market:
https://www.thebusinessresearchcompany.com/report/vascular-embolization-global-market-report

According to The Business Research Company’s Vascular Embolization Global Market Report 2024, The vascular embolization market size has grown strongly in recent years. It will grow from $2.89 billion in 2023 to $3.13 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to rising prevalence of vascular diseases, rise in demand for non-coiling devices, surge in the use of clot agents, increased awareness about advanced treatment options.

The vascular embolization market size is expected to see strong growth in the next few years. It will grow to $4.39 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to growth in the cases of chronic diseases, rising investments in r&d activities, growing preference for minimally invasive procedures, geographic expansion and access to healthcare, rising disposable incomes. Major trends in the forecast period include technological advancements, strategic collaborations, strategic collaborations, development of innovative vascular embolization devices.

The increasing prevalence of vascular diseases is expected to propel the growth of the vascular embolization market going forward. Vascular disease refers to a group of disorders that affect the blood vessels, including the arteries and veins, decrease blood flow, and lead to a variety of conditions such as peripheral vascular disease, abdominal aortic aneurysm, deep vein thrombosis, atherosclerosis, chronic venous insufficiency, peripheral artery diseases, and others. Vascular embolization is used for treating vascular disorders that involve occluding or obstructing blood vessels to stop bleeding, repair aneurysms, and improve blood supply in veins. For instance, in April 2023, according to HMP Communications LLC, a US-based patient-centered education resource, the global prevalence of peripheral artery diseases (PAD) reached 21 million in 2020, estimated to reach 23.8 million by 2030. Therefore, the increasing prevalence of vascular diseases is driving the growth of the vascular embolization market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=12660&type=smp

The vascular embolization market covered in this report is segmented –

1) By Product: Embolic Agents, Embolization Devices
2) By Embolization Technique: Coiling Devices, Non-Coiling Devices
3) By Application: Peripheral Vascular Diseases, Oncology, Urology, Neurology, Other Applications
4) By End Users: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Diagnostic Centers

Technological advancements are a key trend gaining popularity in the vascular embolization market. Major companies operating in the vascular embolization market are developing new technologies to sustain their position in the market. For instance, in June 2022, India Medtronic Private Limited, a subsidy of Medtronic plc, a US-based medical device company, introduced Pipeline Vantage, a flex embolization device to treat brain aneurysms. Pipeline Vantage with shield technology is a revolutionary flow diverter with improved delivery design characteristics. These device characteristics make it easier and more reliable for clinicians to transport, deploy, and treat brain aneurysms and intracranial aneurysms while also providing a scaffold that encourages cell proliferation in the inner lining of the target blood vessel.

The vascular embolization market report table of contents includes: